Alfa Laval launches the first premium separator system for single-use biopharma processing

14 Apr 2020

The CultureOne separator system uses product-contact parts that are replaceable and made from recyclable material.

Alfa Laval has launched a unique separator system, Alfa Laval CultureOne, for single-use processing in the biopharmaceutical industry.

Alfa Laval launches the first premium separator system for single-use biopharma processing

All product-contact parts in the separator system can be replaced after each batch, which limits the need for onsite cleaning and sterilization, and eliminates the risk of cross-contamination, thereby increasing process hygiene and safety, as well as significantly improved turnaround time.

In addition, all product-contact parts are made from recyclable material, which chimes with the company's claims that its innovative technologies are "dedicated to purifying, refining, and reusing materials".

The Alfa Laval CultureOne separator system will be used in processes for harvesting fragile cell cultures which later can be used for injectable drugs for treating life-threatening illnesses such as cancer, rheumatoid arthritis and organ transplant rejection.

Nish Patel, President of the company's Food & Water Division said: "Now we can offer a premium separation technology for more effective production of smaller batches of targeted treatments. It is beneficial for our customers and society."

Read More

Related news

Can the industry really claim it's 'business as usual'?

Can the industry really claim it's 'business as usual'?

19 May 2020

ChargePoint Technology's Chief Commercial Officer says "yes" it can.

Read more 
HKBU scientists develop technique to eliminate drug side effects

HKBU scientists develop technique to eliminate drug side effects

19 May 2020

The novel method paves the way towards the mass production of affordable therapeutic drugs that are made with recyclable materials.

Read more 
Samsung Biologics expands business continuity excellence with additional ISO 22301 certification

Samsung Biologics expands business continuity excellence with additional ISO 22301 certification

19 May 2020

The certification is expected to instill greater 'supply' trust with clients, particularly during the current pandemic.

Read more 
Vibalogics agrees to additional manufacturing for lead COVID-19 vaccine candidate of J&J unit

Vibalogics agrees to additional manufacturing for lead COVID-19 vaccine candidate of J&J unit

18 May 2020

CDMO is contracted to produce multiple clinical batches from German facility

Read more 
Pharmapack expert recommends holistic approach to sustainability

Pharmapack expert recommends holistic approach to sustainability

18 May 2020

Although the industry might be 30% along its sustainability journey, greater interoperability is needed from materials to devices.

Read more 
KND Labs earns Active Pharmaceutical Ingredients certification for CBD ingredients

KND Labs earns Active Pharmaceutical Ingredients certification for CBD ingredients

12 May 2020

Company's manufacturing methods and processes reviewed by an independent third-party auditor to ensure the products have the highest-quality ingredients possible.

Read more 
Characterizing virus and virus-like particles

Characterizing virus and virus-like particles

12 May 2020

New application study describes the separation and characterisation of adeno associated virus serotypes by AF4.

Read more 
Recipharm increases API and raw material stocks to ensure supply amid higher antibiotics demand

Recipharm increases API and raw material stocks to ensure supply amid higher antibiotics demand

12 May 2020

CDMO says it has made "notable changes" to its supply chain processes to ensure continuing supply of medicines during COVID-19 pandemic

Read more 
AI technology company launches with Novartis and Sarepta deals

AI technology company launches with Novartis and Sarepta deals

11 May 2020

Collaborations focus on gene therapies for serious eye and muscle diseases using Dyno’s CapsidMap artificial intelligence platform to design AAV vectors.

Read more 
Demand for immunity products to be sustained long-term says SIRIO

Demand for immunity products to be sustained long-term says SIRIO

11 May 2020

Movement towards healthy lifestyles and preventative supplements the lasting behavioural change post COVID-19.

Read more